Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine for Older Adults with Treatment-Resistant Depression
NCT04504175Phase 4Completed
- Sponsor
- Washington University School of Medicine
- Start
- Oct 2020
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 4 trial of ketamine in major depressive disorder (MDD), sponsored by Washington University School of Medicine. Started Oct 2020; status: completed.
02
Drugs
ketamine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT04504175.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04504175.